Verve Therapeutics, Inc.
Institutional Ownership & Holdings Analysis
About
verve-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | Alphabet Inc.(2025-03-31) | $56.4M |
| 2 | BlackRock, Inc.(2025-03-31) | $36.0M |
| 3 | BVF INC/IL(2025-03-31) | $31.6M |
| 4 | Casdin Capital, LLC(2025-03-31) | $18.3M |
| 5 | VANGUARD GROUP INC(2025-03-31) | $18.1M |
| 6 | STATE STREET CORP(2025-03-31) | $14.1M |
| 7 | Novo Holdings A/S(2025-03-31) | $13.7M |
| 8 | Schonfeld Strategic Advisors LLC(2025-03-31) | $13.4M |
| 9 | Woodline Partners LP(2025-03-31) | $12.6M |
| 10 | T. Rowe Price Investment Management, Inc.(2025-03-31) | $11.4M |
| 11 | MILLENNIUM MANAGEMENT LLC(2025-03-31) | $9.6M |
| 12 | ARCH Venture Management, LLC(2025-03-31) | $9.1M |
| 13 | BAKER BROS. ADVISORS LP(2025-03-31) | $7.7M |
| 14 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $7.7M |
| 15 | BANK OF AMERICA CORP /DE/(2025-03-31) | $7.5M |
| 16 | Nuveen Asset Management, LLC(2024-12-31) | $7.4M |
| 17 | FMR LLC(2025-03-31) | $6.5M |
| 18 | GOLDMAN SACHS GROUP INC(2025-03-31) | $6.5M |
| 19 | Point72 Asset Management, L.P.(2025-03-31) | $6.4M |
| 20 | Nuveen, LLC(2025-03-31) | $6.1M |
As of 2025-03-31
Value:$56.4M
As of 2025-03-31
Value:$36.0M
As of 2025-03-31
Value:$31.6M
As of 2025-03-31
Value:$18.3M
As of 2025-03-31
Value:$18.1M
As of 2025-03-31
Value:$14.1M
As of 2025-03-31
Value:$13.7M
As of 2025-03-31
Value:$13.4M
As of 2025-03-31
Value:$12.6M
As of 2025-03-31
Value:$11.4M
As of 2025-03-31
Value:$9.6M
As of 2025-03-31
Value:$9.1M
As of 2025-03-31
Value:$7.7M
As of 2025-03-31
Value:$7.7M
As of 2025-03-31
Value:$7.5M
As of 2024-12-31
Value:$7.4M
#17FMR LLC
As of 2025-03-31
Value:$6.5M
As of 2025-03-31
Value:$6.5M
As of 2025-03-31
Value:$6.4M
#20Nuveen, LLC
As of 2025-03-31
Value:$6.1M
Total Institutional Holders:211
Top 10 Holders Own:58.7%